Cite
HARVARD Citation
Woodcock, V. et al. (2023). PemBla: A Phase 1 study of intravesical pembrolizumab in recurrent non‐muscle‐invasive bladder cancer. BJUI Compass. 4 (3), pp. 322-330. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Woodcock, V. et al. (2023). PemBla: A Phase 1 study of intravesical pembrolizumab in recurrent non‐muscle‐invasive bladder cancer. BJUI Compass. 4 (3), pp. 322-330. [Online].